Corporate News: Opt Machine Vision Tech (688686.SS)
Opt Machine Vision Tech has maintained a flat trading session (0 % change) on the Shanghai Stock Exchange during the 24‑hour period ending at 12:59 PM Central Europe on Thursday, 22 October 2026. The share price currently sits at CNY 129.85, with an available supply of 112.6 million shares and a market capitalization of CNY 14.8 billion. In the past 24 hours, the company has traded approximately CNY 566.8 million of volume, reflecting a healthy liquidity profile.
Short‑Term Performance Metrics
| Indicator | Value |
|---|---|
| 24‑hour change | 0 % |
| Current price | CNY 129.85 |
| Market cap | CNY 14.8 bn |
| 24‑hour volume | CNY 566.8 mn |
| 200‑day simple moving average | CNY 133.71 |
| 52‑week high | CNY 187.00 (1 July 2026) |
| 52‑week low | CNY 85.89 (23 March 2026) |
The -6.62 % decline since the end of the previous month underscores a modest retracement, yet the stock remains comfortably above its 200‑day SMA, signalling continued bullish momentum in the medium term.
Market Context
On 20 October, the China STAR Market reported a slight dip in the overall financing balance while short‑selling activity edged up. The aggregate margin‑finance and short‑sell balance reached CNY 318.75 billion, a marginal decline from the prior day.
Several peers have exhibited divergent borrowing trends:
- Xinyuan Micro, Nearshore Protein, and Crystal Precision Equipment increased borrowing.
- Jiewa Technology and Juxin Technology experienced notable decreases.
Short‑selling leaders included Hanshan Technology and Zhongxin International; Aerospace Technology and Clean Life Medical saw elevated short‑sell volumes. This mixed behaviour suggests investors are recalibrating their exposure to the sector, balancing optimism for growth with caution over valuation.
Peer Snapshot (Last 24 Hours)
| Stock | 24‑hour change | Current price | Market cap | Notes |
|---|---|---|---|---|
| Col Global (300364.SZ) | 0 % | CNY 23.66 | CNY 17.7 bn | Flat |
| Sichuan Hebang Biotechnol (603077.SS) | 0 % | CNY 2.10 | CNY 17.7 bn | Flat |
| Betta L (300558.SZ) | 0 % | CNY 41.77 | CNY 17.6 bn | P/E = 37.69; eye‑care trials failed, but oncology and KRAS initiatives remain active |
| Zhejiang Publishing & Medi (601921.SS) | 0 % | CNY 7.67 | CNY 17.6 bn | P/E = 13.34 |
| Wuxi Nce Power (605111.SS) | 0 % | CNY 40.50 | CNY 17.7 bn | P/E = 57.34 |
Forward Outlook
Opt Machine Vision Tech’s core competency in vision‑based automation positions it favorably amidst the global push for Industry 4.0 and smart manufacturing. With a solid capital base and a price comfortably above its long‑term moving average, the company is poised to capitalize on emerging opportunities in automotive, consumer electronics, and industrial robotics.
Short‑term market sentiment may remain subdued, but the underlying fundamentals—robust R&D pipeline, strategic partnerships, and a growing client base—provide a resilient foundation. Investors should monitor the company’s earnings releases and any updates on its flagship product launches, as these will likely serve as catalysts for renewed upside momentum.
